We report a case of acquired sideroblastic anaemia precipitated by pro
gesterone. On two separate occasions, over 15 years apart, the patient
developed sideroblastic anaemia with iron overload shortly after the
administration of progesterone. No other cause for sideroblastic anaem
ia was found, and treatment with folic acid, pyridoxine or androgens c
orrected the anaemia. In both instances removal of the progestational
agent led to prompt disappearance of the anaemia as well as the ringed
sideroblasts. Using a two-phase liquid culture procedure in which hum
an peripheral blood-derived progenitor cells undergo erythroid prolife
ration and differentiation, we demonstrated enhanced sensitivity of th
e patient's erythroid progenitors to progesterone. We conclude that pr
ogesterone should be added to the list of medications known to be asso
ciated with acquired sideroblastic anaemia.